LeMaitre Vascular, Inc. (NASDAQ:LMAT) Short Interest Update

LeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) saw a significant growth in short interest in December. As of December 31st, there was short interest totalling 1,210,000 shares, a growth of 37.5% from the December 15th total of 880,000 shares. Approximately 5.9% of the company's stock are short sold. Based on an average daily volume of 157,900 shares, the short-interest ratio is currently 7.7 days.

LeMaitre Vascular Price Performance

Shares of NASDAQ:LMAT traded up $0.47 during midday trading on Thursday, reaching $98.23. The company's stock had a trading volume of 99,715 shares, compared to its average volume of 152,742. LeMaitre Vascular has a fifty-two week low of $56.04 and a fifty-two week high of $109.58. The business's fifty day simple moving average is $98.64 and its 200-day simple moving average is $91.62. The company has a market capitalization of $2.21 billion, a P/E ratio of 53.68, a P/E/G ratio of 2.07 and a beta of 0.96.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last posted its quarterly earnings results on Thursday, October 31st. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.44 by $0.05. The business had revenue of $54.82 million for the quarter, compared to analysts' expectations of $53.50 million. LeMaitre Vascular had a return on equity of 13.15% and a net margin of 19.40%. The firm's quarterly revenue was up 15.6% compared to the same quarter last year. During the same quarter last year, the business earned $0.33 earnings per share. On average, analysts forecast that LeMaitre Vascular will post 1.94 earnings per share for the current fiscal year.

LeMaitre Vascular Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, December 5th. Investors of record on Thursday, November 21st were paid a dividend of $0.16 per share. The ex-dividend date of this dividend was Thursday, November 21st. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.65%. LeMaitre Vascular's dividend payout ratio (DPR) is presently 34.97%.

Insider Activity

In other news, Director Bridget A. Ross sold 3,750 shares of the business's stock in a transaction on Friday, November 15th. The shares were sold at an average price of $101.47, for a total transaction of $380,512.50. Following the transaction, the director now directly owns 2,278 shares in the company, valued at $231,148.66. The trade was a 62.21 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 10.79% of the company's stock.

Hedge Funds Weigh In On LeMaitre Vascular

Several institutional investors have recently modified their holdings of LMAT. Driehaus Capital Management LLC grew its holdings in shares of LeMaitre Vascular by 52.2% in the 2nd quarter. Driehaus Capital Management LLC now owns 264,217 shares of the medical instruments supplier's stock valued at $21,740,000 after buying an additional 90,573 shares during the period. DF Dent & Co. Inc. increased its stake in LeMaitre Vascular by 26.2% in the 3rd quarter. DF Dent & Co. Inc. now owns 258,767 shares of the medical instruments supplier's stock valued at $24,037,000 after buying an additional 53,797 shares during the last quarter. Conestoga Capital Advisors LLC increased its position in shares of LeMaitre Vascular by 1.9% in the third quarter. Conestoga Capital Advisors LLC now owns 1,978,351 shares of the medical instruments supplier's stock valued at $183,769,000 after acquiring an additional 36,850 shares during the last quarter. Rice Hall James & Associates LLC raised its stake in shares of LeMaitre Vascular by 15.7% during the 3rd quarter. Rice Hall James & Associates LLC now owns 261,306 shares of the medical instruments supplier's stock worth $24,273,000 after purchasing an additional 35,383 shares in the last quarter. Finally, F M Investments LLC raised its position in LeMaitre Vascular by 36.6% during the third quarter. F M Investments LLC now owns 123,545 shares of the medical instruments supplier's stock worth $11,476,000 after acquiring an additional 33,087 shares in the last quarter. 84.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. Oppenheimer restated an "outperform" rating and issued a $93.00 price objective (up previously from $90.00) on shares of LeMaitre Vascular in a report on Friday, November 1st. Cantor Fitzgerald began coverage on LeMaitre Vascular in a research report on Tuesday, October 15th. They set a "neutral" rating and a $96.00 price objective for the company. StockNews.com downgraded shares of LeMaitre Vascular from a "buy" rating to a "hold" rating in a report on Friday, December 13th. Finally, Barrington Research raised their price objective on LeMaitre Vascular from $92.00 to $93.00 and gave the stock an "outperform" rating in a research report on Friday, November 1st. Three equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $94.57.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.